Your browser doesn't support javascript.
loading
Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.
Zeng, Tian-Mei; Pan, Yu-Fei; Yuan, Zhen-Gang; Chen, Dong-Sheng; Song, Yun-Jie; Gao, Yong.
Afiliação
  • Zeng TM; School of Medicine, Tongji University, Shanghai, China.
  • Pan YF; Department of Oncology, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Yuan ZG; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Chen DS; Department of Oncology, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Song YJ; Jiangsu Simcere Diagnostics Co., Ltd, The State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China.
  • Gao Y; Jiangsu Simcere Diagnostics Co., Ltd, The State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China.
Front Immunol ; 13: 943066, 2022.
Article em En | MEDLINE | ID: mdl-36159865
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article